Allogene Therapeutics, Inc. (ALLO)
NASDAQ·Healthcare·Biotechnology
$1.02
-2.63%
Mkt Cap $376.58M
Analyst Ratings
No recent rating data.
Price Target (12 analysts)
$26.53
Range $3.85 – $55.00
Implied Upside
+2506.9%
Consensus $26.53 vs current $1.02
NASDAQ·Healthcare·Biotechnology
$1.02
-2.63%
Mkt Cap $376.58M
No recent rating data.
Price Target (12 analysts)
$26.53
Range $3.85 – $55.00
+2506.9%
Consensus $26.53 vs current $1.02